353 related articles for article (PubMed ID: 22667993)
1. Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.
El-Nikhely N; Larzabal L; Seeger W; Calvo A; Savai R
Expert Opin Investig Drugs; 2012 Aug; 21(8):1107-22. PubMed ID: 22667993
[TBL] [Abstract][Full Text] [Related]
2. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets.
Wood SL; Pernemalm M; Crosbie PA; Whetton AD
Cancer Treat Rev; 2014 May; 40(4):558-66. PubMed ID: 24176790
[TBL] [Abstract][Full Text] [Related]
3. New molecular targeted therapies integrated with radiation therapy in lung cancer.
Provencio M; Sánchez A; Garrido P; Valcárcel F
Clin Lung Cancer; 2010 Mar; 11(2):91-7. PubMed ID: 20199974
[TBL] [Abstract][Full Text] [Related]
4. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
5. Preclinical strategies targeted at non-small-cell lung cancer signalling pathways with striking translational fallout.
Favoni RE; Alama A
Drug Discov Today; 2013 Jan; 18(1-2):11-24. PubMed ID: 22885521
[TBL] [Abstract][Full Text] [Related]
6. Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents.
Gridelli C; Rossi A; Maione P
Oncogene; 2003 Sep; 22(42):6629-38. PubMed ID: 14528288
[TBL] [Abstract][Full Text] [Related]
7. Gefitinib (ZD1839, Iressa) in non-small-cell lung cancer: a review of clinical trials from a daily practice perspective.
Barlési F; Tchouhadjian C; Doddoli C; Villani P; Greillier L; Kleisbauer JP; Thomas P; Astoul P
Fundam Clin Pharmacol; 2005 Jun; 19(3):385-93. PubMed ID: 15910663
[TBL] [Abstract][Full Text] [Related]
8. New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.
Crawford J
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S78-86. PubMed ID: 19795580
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy of non-small-cell lung carcinoma.
Tiwari D; Brodie SA; Brandes JC
Ther Adv Respir Dis; 2012 Feb; 6(1):41-56. PubMed ID: 21730004
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of platelet-derived growth factor receptor α by MEDI-575 reduces tumor growth and stromal fibroblast content in a model of non-small cell lung cancer.
Laing N; McDermott B; Wen S; Yang D; Lawson D; Collins M; Reimer C; Hall PA; Andersén H; Snaith M; Wang X; Bedian V; Cao ZA; Blakey D
Mol Pharmacol; 2013 Jun; 83(6):1247-56. PubMed ID: 23558446
[TBL] [Abstract][Full Text] [Related]
11. EGFR inhibitors with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer.
Xu Y; Zhang Y; Ma S
Lung Cancer; 2011 Sep; 73(3):249-55. PubMed ID: 21641672
[TBL] [Abstract][Full Text] [Related]
12. Metastatic non-small cell lung cancer management: novel targets and recent clinical advances.
Riess JW; Wakelee HA
Clin Adv Hematol Oncol; 2012 Apr; 10(4):226-34. PubMed ID: 22706483
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapies for non-small cell lung cancer.
Dempke WC; Suto T; Reck M
Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
[TBL] [Abstract][Full Text] [Related]
14. The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer.
Langer C; Soria JC
Clin Lung Cancer; 2010 Mar; 11(2):82-90. PubMed ID: 20199973
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies in lung cancer.
Wang Y; Deng G; Liu X; Cho WC
Expert Opin Biol Ther; 2013 Feb; 13(2):209-26. PubMed ID: 23240766
[TBL] [Abstract][Full Text] [Related]
16. Emerging drugs for squamous cell lung cancer.
Cheng H; Shcherba M; Kandavelou K; Liang Y; Liu H; Perez-Soler R
Expert Opin Emerg Drugs; 2015 Mar; 20(1):149-60. PubMed ID: 25557559
[TBL] [Abstract][Full Text] [Related]
17. Targeting stromal-cancer cell interactions with siRNAs.
Aharinejad S; Sioud M; Lucas T; Abraham D
Methods Mol Biol; 2009; 487():243-66. PubMed ID: 19301651
[TBL] [Abstract][Full Text] [Related]
18. Second-line therapy for non-small-cell lung cancer.
Arango BA; Castrellon AB; Santos ES; Raez LE
Clin Lung Cancer; 2009 Mar; 10(2):91-8. PubMed ID: 19362951
[TBL] [Abstract][Full Text] [Related]
19. Advances in preclinical small molecules for the treatment of NSCLC.
Zhang Q; Feng W; Zhou H; Yan B
Expert Opin Ther Pat; 2009 Jun; 19(6):731-51. PubMed ID: 19456275
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting of tumor-stroma interactions.
Hiscox S; Barrett-Lee P; Nicholson RI
Expert Opin Ther Targets; 2011 May; 15(5):609-21. PubMed ID: 21388336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
